We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
- Authors
Gulick, Roy M; Su, Zhaohui; Flexner, Charles; Hughes, Michael D; Skolnik, Paul R; Wilkin, Timothy J; Gross, Robert; Krambrink, Amy; Coakley, Eoin; Greaves, Wayne L; Zolopa, Andrew; Reichman, Richard; Godfrey, Catherine; Hirsch, Martin; Kuritzkes, Daniel R; AIDS Clinical Trials Group 5211 Team
- Abstract
Vicriviroc, an investigational CCR5 inhibitor, demonstrated short-term antiretroviral activity in a phase 1 study.
- Publication
The Journal of infectious diseases, 2007, Vol 196, Issue 2, p304
- ISSN
0022-1899
- Publication type
Journal Article
- DOI
10.1086/518797